wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46638388-6413885D-8300-4BB6-BFBF-091D352F233F
Q46638388-6413885D-8300-4BB6-BFBF-091D352F233F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46638388-6413885D-8300-4BB6-BFBF-091D352F233F
Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK.
P2860
Q46638388-6413885D-8300-4BB6-BFBF-091D352F233F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46638388-6413885D-8300-4BB6-BFBF-091D352F233F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d6cd272f9ba4ea32f2f729f5fcb8892ed6c736a9
P2860
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada